Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Journal of Cell Science|September 12, 2015
Galactosylsphingosine (psychosine)-induced demyelination is attenuated by sphingosine 1-phosphate signallingCatherine O'Sullivan, Kumlesh K Dev
Trends in Pharmacological Sciences|June 15, 2013
The structure and function of the S1P1 receptorCatherine O'Sullivan, Kumlesh K Dev
Journal of Neuroinflammation|February 10, 2016
The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice culturesCatherine O'Sullivan, Anna Schubart, Anis K Mir, et al.
Journal of Neurochemistry|January 30, 2018
Sphingosine 1-phosphate receptors regulate TLR4-induced CXCL5 release from astrocytes and microgliaSinead A O'Sullivan, Catherine O'Sullivan, Luke M Healy, et al.
Idrugs : the Investigational Drugs Journal|April 6, 2006
Using RNAi in the clinicKumlesh K Dev
Nature Reviews. Drug Discovery|December 2, 2004
Making protein interactions druggable: targeting PDZ domainsKumlesh K Dev
Current Topics in Medicinal Chemistry|February 3, 2007
PDZ domain protein-protein interactions: a case study with PICK1Kumlesh K Dev
Biomedicines|May 27, 2023
The Effects of Antipsychotics in Experimental Models of Krabbe DiseaseKapil Sharma, Kumlesh K Dev
Drug Discovery Today. Therapeutic Strategies|April 15, 2020
RNA interference as a therapeutic strategy for treating CNS disordersDaniel Hoyer, Kumlesh K Dev
Drug Discovery Today|August 27, 2013
Drug dealers: $20 trillion of in-licensing paymentsPatrik Frei, Kumlesh K Dev
Pageof 11